BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System

FRANKLIN LAKES, N.J., July 24, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k)... Devices, FDA BD , Alaris Infusion System
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news